Evidence map›Paper›PMID 36875495›Full record

ArticleCase reports in infectious diseases2023

Minimal Change Nephrotic Syndrome with Acute Kidney Injury after the Administration of Pfizer-BioNTech COVID-19 Vaccine.

Erdinc Gulumsek, Dilan Damla Ozturk, Huseyin Ali Ozturk, Tayyibe Saler, Kivilcim Eren Erdogan, Ahmed Muhammad Bashir, Hilmi Erdem Sumbul

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Erdinc GulumsekDepartment of Gastroenterology, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.
Dilan Damla OzturkDepartment of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.
Huseyin Ali OzturkDepartment of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.
Tayyibe SalerDepartment of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.
Kivilcim Eren ErdoganDepartment of Pathology, Cukurova University Faculty of Medicine, Adana, Turkey.
Ahmed Muhammad BashirDepartment of Internal Medicine, University of Health Science, Mogadishu Somali Turkey Training and Research Hospital, Mogadishu, Somalia.ORCID https://orcid.org/0000-0002-7992-506X
Hilmi Erdem SumbulDepartment of Internal Medicine, University of Health Sciences-Adana Health Practice and Research Center, Adana, Turkey.
Sağlık Bilimleri Üniversitesi · TRCukurova University · TRSomali National University · SO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephrotic syndrome progresses with various metabolic disturbances, such as proteinuria over 3.5 grams in 24 hours, hypoalbuminemia, and hypercoagulability. Patients usually complain about diffuse edema throughout the body, which is secondary to hypoalbuminemia. It has many primary and secondary causes. Patients may require a renal biopsy to confirm the diagnosis. Besides, many secondary causes of nephrotic syndrome should be examined and excluded. Although many vaccines were developed due to the COVID-19, many side effects are still reported because of the Pfizer-BioNTech COVID-19 vaccine (COVID-19 mRNA and BNT162b2), which is widely used in Turkey. This study examines a case of nephrotic syndrome with acute renal injury after Pfizer-BioNTech vaccine.

Identifiers

PMID36875495
PMCPMC9977546
OpenAlexW4321481374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.